• LIVING WITH CRC

    Phase III trial launches to prevent oxaliplatin-induced neuropathy in adjuvant treatment

    The PROSPER trial will test lecithinized superoxide dismutase (PC-SOD) against placebo to prevent chemotherapy-induced peripheral neuropathy in stage II/III colorectal cancer patients receiving adjuvant mFOLFOX6, following promising phase II results. (ESMO Gastrointest Oncol)